Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: A retrospective case series-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: A retrospective case series

Published:2022-10-10 Issue:11 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Sun Yan‐hong¹^ORCID,Man Xiao‐yong¹^ORCID,Xuan Xiu‐yun²,Huang Chang‐zheng²^ORCID,Shen Ying¹^ORCID,Lao Li‐min¹^ORCID

Affiliation:

1. Department of Dermatology The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou Zhejiang China

2. Department of Dermatology Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei China

Publisher

Hindawi Limited

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15848

Reference18 articles.

1. Rosacea: an update in diagnosis, classification and management;Kang CN;Skin Therapy Lett,2021

2. Under Development JAK Inhibitors for Dermatologic Diseases

3. Activation of Janus kinase signaling pathway in acne lesions

4. The therapeutic effect of artesunate on rosacea through the inhibition of the JAK/STAT signaling pathway;Li T;Mol Med Rep,2018

5. Defining treatment success in rosacea as ‘clear’ may provide multiple patient benefits: results of a pooled analysis

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic strategies focusing on immune dysregulation and neuroinflammation in rosacea;Frontiers in Immunology;2024-07-29

2. Treatment of rosacea with upadacitinib and abrocitinib: case report and review of evidence for Janus kinase inhibition in rosacea;Frontiers in Immunology;2024-07-09

3. Targeting the STAT3/IL-36G signaling pathway can be a promising approach to treat rosacea;Journal of Advanced Research;2024-06

4. Rosacea and autoimmune disease: a case-control study in the all of us database;Archives of Dermatological Research;2024-05-25

5. Advances in the Pathogenesis and Treatment of Rosacea: A Phenotype-Based Therapeutic Approach;Cosmetics;2024-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3